Cucurbitacin E

Cucurbitacin E
Skeletal structure of Cucuribitacin E
Identifiers
18444-66-1
ChemSpider 4444696
Jmol interactive 3D Image
PubChem 5281319
UNII V8A45XYI21 YesY
Properties
C32H44O8
Molar mass 556.76 g/mol
Density 1.249 g/cm3
Melting point 228 to 232 °C; 442 to 449 °F; 501 to 505 K
Boiling point 712.47 °C; 1,314.45 °F; 985.62 K
Hazards
Flash point 497.45 °C (927.41 °F; 770.60 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Cucurbitacin E is a biochemical compound from the family of Cucurbitacins. These are found in plants which are member of the family Cucurbitaceae, most of them coming from traditional Chinese medicinal plants, but also in other plants such as pumpkins and gourds.

Cucurbitacin E is a highly oxidated steroid consisting of a tetracyclic triterpene. Specific changes on this molecule under certain conditions can generate other types of Cucurbitacins such as Cucurbitacin I, J, K and L.

Nowadays it is being highly investigated because it has been discovered that this molecule has a wide range of biological properties that could help treating many diseases.


Cucumbers belong to the family Cucurbitaceae
Watermelons are a rich source of Cucurbitacin E

Properties

Anti-inflammatory

Cucurbitacin E anti-inflammatory activities are proved in vivo and in vitro. It is useful in the treatment of inflammation because of the inhibition of cyclooxygenase and reactive nitrogen species but not reactive oxygen species.

Macrophages are responsible for the production of various cytokines, RNS and ROS, growth factors and chemokines as a response to activation signal such as chemical mediators, cytokines and lipopolysaccharide. Although these molecules have an important role, they can also have damaging effects, like some RNS. Cucurbitacin's clue role is that it has a dose-dependent anti-inflammatory activity related with the inhibition of nitric oxide (an RNS) production in macrophages without affecting the viability of these cells.

As cucurbitacin E doesn't affect normal human liver cells, it could have therapeutic potencial and effective treatment for a variety of inflammation mediated diseases.[2]

Antioxidant properties

Cucurbitacin E glycoside was demonstrated as antioxidant and free-radical scavenger. Its antioxidant and free-radical scavenging properties were measured by the ability of Cucurbitacin glycoside combination (CGC),a combination of Cucurbitacin B and E glycosides, to reduce ABTS cation to its original form and also the capacity to inhibit MDA formation originated in the oxidation of linoleic acid. Using electron paramagnetic resonance, it was confirmed that CGC had antioxidant properties because of their capacity to make a scavenging effect on different free radicals: superoxide anion (O2-), hydroxyl radical (OH-) and singlet oxygen. That's relevant because not all the natural antioxidants that have been studied have strong scavenging activity against different radicals.[3]

Therefore, a strong potential could exist for CGC in treating human diseases that are linked to oxidative or free-radical damage such as atherosclerosis, cancer, Alzheimer's disease and diabetes.[4]

Cytostatic

Cucurbitacin E is an important inhibitor during the S to M phase in the cell mitosis. It causes a reduction of cell multiplication. This antiproliferation effect is caused by the cytoskeleton actin disruption induced by Cucurbitacin E.[5]

Cytotoxicity

This triterpene can inhibit the phosphorylation of the cofilin protein, a family of actin-binding proteins that disassembles actin filaments.[6][7]

Therefore, Cucurbitacin E can induce to tumoral-cell apoptosis and can also reduce cancer metastasis. It is tested that Cucurbitacin E shows cytotoxicity to:[8]

Anti-angiogenesis

Cucurbitacin can also inhibit VEGFR2-mediated Jak-STAT3[8] and MAPK signaling pathways. Anti-angiogenesis property of cucurbitacin E was demonstrated in vitro but also in vivo in a chick embryo chorioallantoic membrane and in a mouse corneal angiogenesis model.

Anti-invasion and anti-metastasis

Cucurbitacin E inhibits the adhesion of cancer cells in type I collagen .[8]

Hepatoprotecive effect

Cucurbitacin-E protects hepatocytes from CCl4 (carbon tetrachloride), by reducing GPT, GOT, ALP, TP and TBIL serums.[8]

See also

External links

References

  1. ↑ Torkey, H.M., Abou-Yousef, H.M., Abdel Azeiz, A.Z. and Hoda, E.A. Farid. Insecticidal Effect of Cucurbitacin E Glycoside Isolated from Citrullus colocynthis Against Aphis craccivora. Australian Journal of Basic and Applied Sciences 2009; 3(4): 4060-4066
  2. ↑ Abdelwahab, S. I.; Hassan, L. E. A.; Sirat, H. M.; Yagi, S. M. A.; Koko, W. S.; Mohan, S.; Taha, M. M. E.; Ahmad, S.; Chuen, C. S.; Narrima, P.; Rais, M. M.; Hadi, A. H. A. (2011). "Anti-inflammatory activities of cucurbitacin E isolated from Citrullus lanatus var. Citroides: Role of reactive nitrogen species and cyclooxygenase enzyme inhibition". Fitoterapia 82 (8): 1190–1197. doi:10.1016/j.fitote.2011.08.002. PMID 21871542.
  3. ↑ Tannin-Spitz, T.; Bergman, M.; Grossman, S. (2007). "Cucurbitacin glucosides: Antioxidant and free-radical scavenging activities". Biochemical and Biophysical Research Communications 364 (1): 181–186. doi:10.1016/j.bbrc.2007.09.075. PMID 17942079.
  4. ↑ Clancy, D.; Birdsall, J. (2012). "Flies, worms and the Free Radical Theory of ageing". Ageing Research Reviews 12 (1): 404–12. doi:10.1016/j.arr.2012.03.011. PMID 22504404.
  5. ↑ Zia-Ul-Haq, M; Kausar, A; Shahid, SA; Qayum, M; Ahmad, S; Khan, I (2012). "Phytopharmacological profile of Gratiola officinalis Linn.: A review" (PDF). Journal of Medicinal Plants Research 6 (16): 3087–3092. doi:10.5897/jmpr12.172.
  6. ↑ Drubin, D. G.; Lappalainen, P. (1997). "Cofilin promotes rapid actin filament turnover in vivo". Nature 388 (6637): 78–82. doi:10.1038/40418. PMID 9214506.
  7. ↑ Nakashima, S.; Matsuda, H.; Kurume, A.; Oda, Y.; Nakamura, S.; Yamashita, M.; Yoshikawa, M. (2010). "Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells". Bioorganic & Medicinal Chemistry Letters 20 (9): 2994–2997. doi:10.1016/j.bmcl.2010.02.062. PMID 20347305.
  8. 1 2 3 4 Chen, X.; Bao, J.; Guo, J.; Ding, Q.; Lu, J.; Huang, M.; Wang, Y. (2012). "Biological activities and potential molecular targets of cucurbitacins". Anti-Cancer Drugs 23 (8): 777–787. doi:10.1097/CAD.0b013e3283541384. PMID 22561419.

Further reading

This article is issued from Wikipedia - version of the Wednesday, February 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.